Ligand Pharmaceuticals Inc (LGND)
Capital Expenditure
-$278.00K
TTM · Period ending: · USD
LGND Capital Expenditure
Latest reported-$278.00Kperiod ending
Latest reported-$278.00Kperiod ending
LGND TTM CapEx (-$600.00K → -$278.00K)
TTM CapEx
High-resolution chart · PNG
LGND capital expenditure history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -278,000 | |
| -466,000 | |
| -452,000 | |
| -1,155,000 | |
| -15,381,000 | |
| -17,306,000 | |
| -17,197,000 | |
| -16,902,000 | |
| -3,148,000 | |
| -1,212,000 | |
| -3,521,000 | |
| -5,235,000 | |
| -10,037,000 | |
| -16,422,000 | |
| -18,883,000 | |
| -18,947,000 | |
| -15,430,000 | |
| -13,636,000 | |
| -12,165,000 | |
| -14,428,000 | |
| -14,693,000 | |
| -10,690,000 | |
| -7,286,000 | |
| -5,381,000 | |
| -3,344,000 | |
| -2,553,000 | |
| -2,553,000 | |
| -10,887,000 | |
| -10,887,000 | |
| -10,887,000 | |
| -11,887,000 | |
| -2,936,000 | |
| -2,957,000 | |
| -3,069,000 | |
| -7,154,000 | |
| -7,007,000 | |
| -9,172,000 | |
| -27,723,000 | |
| -28,322,000 | |
| -28,398,000 | |
| -27,490,000 | |
| -13,290,000 | |
| -10,863,000 | |
| -11,561,000 | |
| -10,550,000 | |
| -6,132,000 | |
| -4,499,000 | |
| -2,939,000 | |
| -2,877,000 | |
| -6,524,000 | |
| -4,937,000 | |
| -11,945,000 | |
| -12,112,000 | |
| -8,662,000 | |
| -8,644,000 | |
| -595,000 | |
| -334,000 | |
| -92,000 | |
| -78,000 | |
| 1,259,000 | |
| 1,365,000 | |
| -19,000 | |
| -70,000 | |
| -1,430,000 | |
| -1,642,000 | |
| -364,000 | |
| -522,000 | |
| -578,000 | |
| -430,000 | |
| -513,000 | |
| -495,000 | |
| -525,000 | |
| -494,000 | |
| -550,000 | |
| -440,000 | |
| -560,000 | |
| -1,440,000 | |
| -1,679,000 | |
| -1,783,000 | |
| -1,860,000 | |
| -35,125,000 | |
| -35,189,000 | |
| -35,596,000 | |
| -36,089,000 | |
| -2,728,000 | |
| -3,249,000 | |
| -3,604,000 | |
| -4,385,000 | |
| -4,359,000 | |
| -3,497,000 | |
| -2,783,000 | |
| -1,522,000 | |
| -1,435,000 | |
| -1,904,000 | |
| -3,161,000 | |
| -3,323,000 | |
| -2,805,000 | |
| -2,606,000 | |
| -1,974,000 | |
| -1,579,000 |